AL
IVE icon

Aspiriant LLC’s iShares S&P 500 Value ETF IVE Stock Holding History

Aspiriant LLC’s Portfolio IVE Stock Details IVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$936K Buy
4,432
+105
+2% +$22.7K 0.03% 161
2025
Q4 		$918K Buy
4,327
+103
+2% +$21.6K 0.03% 166
2025
Q3 		$872K Sell
4,224
-4,224
-50% -$848K 0.03% 157
2025
Q2 		$1.65M Buy
8,448
+4,198
+99% +$782K 0.05% 113
2025
Q1 		$810K Buy
4,250
+26
+0.6% +$5.03K 0.03% 155
2024
Q4 		$806K Buy
4,224
+85
+2% +$16.9K 0.03% 159
2024
Q3 		$816K Buy
4,139
+1
+0% +$190 0.03% 157
2024
Q2 		$753K Hold
4,138
– – 0.03% 161
2024
Q1 		$773K Sell
4,138
-186
-4% -$33.1K 0.03% 159
2023
Q4 		$752K Hold
4,324
– – 0.03% 163
2023
Q3 		$665K Sell
4,324
-211
-5% -$34.1K 0.03% 160
2023
Q2 		$731K Buy
4,535
+206
+5% +$31.7K 0.04% 159
2023
Q1 		$657K Sell
4,329
-1,239
-22% -$187K 0.03% 158
2022
Q4 		$808K Buy
5,568
+1,239
+29% +$177K 0.04% 143
2022
Q3 		$557K Sell
4,329
-70
-2% -$9.92K 0.03% 161
2022
Q2 		$604K Buy
4,399
+2,355
+115% +$348K 0.03% 153
2022
Q1 		$319K Hold
2,044
– – 0.02% 219
2021
Q4 		$319K Buy
+2,044
New +$311K 0.02% 226
2020
Q1 		– Sell
-1,617
Closed -$210K – 201
2019
Q4 		$210K Sell
1,617
-224
-12% -$27.9K 0.02% 192
2019
Q3 		$220K Sell
1,841
-45
-2% -$5.28K 0.02% 205
2019
Q2 		$220K Buy
1,886
+49
+3% +$5.61K 0.02% 208
2019
Q1 		$208K Sell
1,837
-2,825
-61% -$310K 0.02% 217
2018
Q4 		$471K Sell
4,662
-992
-18% -$109K 0.04% 146
2018
Q3 		$655K Sell
5,654
-2,333
-29% -$268K 0.06% 137
2018
Q2 		$880K Hold
7,987
– – 0.08% 114
2018
Q1 		$873K Buy
+7,987
New +$913K 0.08% 114
2017
Q4 		– Sell
-8,992
Closed -$970K – 129
2017
Q3 		$970K Sell
8,992
-1,835
-17% -$194K 0.08% 108
2017
Q2 		$1.14M Sell
10,827
-167
-2% -$17.4K 0.1% 104
2017
Q1 		$1.14M Sell
10,994
-436
-4% -$45.3K 0.1% 110
2016
Q4 		$1.16M Sell
11,430
-930
-8% -$90.7K 0.1% 101
2016
Q3 		$1.17M Sell
12,360
-633
-5% -$60.2K 0.12% 98
2016
Q2 		$1.21M Buy
12,993
+73
+0.6% +$6.68K 0.11% 98
2016
Q1 		$1.16M Buy
+12,920
New +$1.1M 0.11% 96
2015
Q3 		– Sell
-2,950
Closed -$272K – 114
2015
Q2 		$272K Buy
+2,950
New +$278K 0.03% 91
2015
Q1 		– Sell
-2,430
Closed -$228K – 95
2014
Q4 		$228K Buy
2,430
+6
+0.2% +$550 0.03% 83
2014
Q3 		$218K Buy
2,424
+6
+0.2% +$545 0.03% 75
2014
Q2 		$218K Buy
2,418
+6
+0.2% +$530 0.03% 77
2014
Q1 		$210K Sell
2,412
-1,367
-36% -$115K 0.03% 80
2013
Q4 		$323K Buy
+3,779
New +$311K 0.05% 64
2013
Q3 		– Sell
-3,738
Closed -$283K – 57
2013
Q2 		$283K Buy
+3,738
New +$284K 0.04% 53

Other funds holding IVE

Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Aspiriant LLC's IVE Position: Q1 2026 in Review

Aspiriant LLC increased its iShares S&P 500 Value ETF (IVE) stake by 2.4% in Q1 2026, buying an estimated $22.7K and bringing the position to 4,432 shares worth $936K. The position accounts for 0.03% of the portfolio, ranked #161.

Aspiriant LLC first reported a position in IVE in Q2 2013 and has held it in 40 quarters since. The position peaked at $1.65M in Q2 2025. 1,704 funds tracked by Wall St. Rank hold IVE as of Q1 2026.

  • Aspiriant LLC held 4,432 shares of iShares S&P 500 Value ETF worth $936K as of Q1 2026.
  • Aspiriant LLC bought 105 iShares S&P 500 Value ETF shares in Q1 2026, an estimated $22.7K.
  • iShares S&P 500 Value ETF made up 0.03% of Aspiriant LLC's portfolio in Q1 2026, its #161 holding.
  • Aspiriant LLC first reported a position in iShares S&P 500 Value ETF in Q2 2013 and has held it in 40 quarters since.
  • Aspiriant LLC's iShares S&P 500 Value ETF position peaked at $1.65M in Q2 2025.
  • 1,704 funds tracked by Wall St. Rank held iShares S&P 500 Value ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.